More on INSM
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $107.41 |
|
|||
| Open | $106.49 | ||||
| 52 Wk High | $19.30 | ||||
| 52 Wk Low | $9.02 | ||||
| Day High | $108.27 | ||||
| Day Low | $105.77 | ||||
| P/E | N/A | ||||
| EPS | $-1.69 | ||||
| Volume | 1,908,294 | ||||
- Form 4 INSMED Inc For: Jul 23 Filed by: Lewis William
- Form 144 INSMED Inc Filed by: Lewis William
- Insmed to Host Second-Quarter 2026 Financial Results Conference Call on Thursday, August 6, 2026
- Form SCHEDULE 13G/A INSMED Inc Filed by: JPMORGAN CHASE & CO
- Raymond James sees potential for beats across biopharma coverage
- BMO Capital Starts Insmed (INSM) at Outperform
- H.C. Wainwright Reiterates Buy Rating on Insmed (INSM)
- Insmed (INSM) Reiterated at Buy by Stifel After TPIP P2b Trial Data
- Insmed reports 12-month OLE data for TPIP in PAH patients
- Form 8-K INSMED Inc For: Jul 16
Entities mentioned with INSM
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- 13G | View Related Stories »
- Definitive Agreement | View Related Stories »
- Stifel | View Related Stories »
- Show More...
